An IP litigator with a scientific background, Sidd advises clients across a broad range of technologies, especially in disputes having an international element and involving complex technical issues.
 
Sidd specialises in multi-jurisdictional patent litigation in the medtech, biotech and pharmaceutical sectors. He has represented clients in litigation before the UK Patents Court, Court of Appeal and Supreme Court, as well as in EPO proceedings – and has successfully acted for clients in some of the most high-profile patent cases to come before the UK courts in recent years, including the landmark UK Supreme Court decisions in Warner-Lambert v Actavis and Regeneron v Kymab.
 
Sidd has considerable experience of actively assisting with litigation in various European courts and the coordination with parallel US litigation.  He also advises on freedom to operate, regulatory issues and matters of confidential information. 
 
 
Sidd joined Powell Gilbert as an associate in 2012, and became a partner in 2019.
 

Key cases

•  Regeneron v Kymab (biotech – antibodies / transgenic mice)

• Advanced Bionics v MED-EL (medical devices – cochlear implants)

• Edwards Lifesciences v Meril (medical devices – transcatheter heart valves)

• Abbott v Edwards Lifesciences (medical devices – transcatheter mitral valve repair)

• Warner-Lambert v Actavis & Others (pregabalin)

• AIM Sport Vision v Supponor (technology – augmented reality)

• Forty Seven v SSB (biotech – therapeutic antibodies)

• Edwards Lifesciences v Boston Scientific (medical devices - transcatheter heart valves) 

• Merck Sharp & Dohme v Royalty Pharma Collection Trust (pharmacueticals – DPP-IV inhibitors)

• CompactGTL v Velocys (engineering – catalysts) 

• TCT v Ericsson (telecommunications)

• Mölnlycke v BSN Medical (wound dressings)

• HTC v Apple (smartphones)

• L’Oréal v eBay (trade mark – e-commerce / keyword advertising)